FUJII, M., ICHIKAWA, M., IWATATE, K., BAKHIT, M., YAMADA, M., KUROMI, Y., . . . SAITO, K. (2020). Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients. Neurol Med Chir (Tokyo).
Παραπομπή Chicago StyleFUJII, Masazumi, Masahiro ICHIKAWA, Kensho IWATATE, Mudathir BAKHIT, Masayuki YAMADA, Yosuke KUROMI, Taku SATO, Jun SAKUMA, και Kiyoshi SAITO. "Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients." Neurol Med Chir (Tokyo) 2020.
Παραπομπή MLAFUJII, Masazumi, et al. "Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients." Neurol Med Chir (Tokyo) 2020.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.